EP4038056 - PREPARATION OF 2-CHLORO-1-(2-CHLOROTHIAZOL-5-YL)ETHANONE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 13.09.2024 Database last updated on 02.11.2024 | |
Former | The patent has been granted Status updated on 06.10.2023 | ||
Former | Grant of patent is intended Status updated on 31.05.2023 | ||
Former | Request for examination was made Status updated on 08.07.2022 | ||
Former | The international publication has been made Status updated on 10.04.2021 | ||
Former | unknown Status updated on 20.10.2020 | Most recent event Tooltip | 01.11.2024 | Lapse of the patent in a contracting state New state(s): SI | published on 04.12.2024 [2024/49] | Applicant(s) | For all designated states BASF SE Carl-Bosch-Strasse 38 67056 Ludwigshafen am Rhein / DE | [2022/32] | Inventor(s) | 01 /
SHINDE, Harish Thane Belapur Road Navi Mumbai 400705 / IN | 02 /
KADUSKAR, Rahul Thane Belapur Road Navi Mumbai 400705 / IN | 03 /
KORADIN, Christopher Carl-Bosch-Strasse 38 67056 Ludwigshafen / DE | 04 /
MCLAUGHLIN, Martin John Carl-Bosch-Strasse 38 67056 Ludwigshafen / DE | 05 /
GOETZ, Roland Carl-Bosch-Strasse 38 67056 Ludwigshafen / DE | 06 /
KHAMKAR, Sunil Thane Belapur Road Navi Mumbai 400705 / IN | [2022/32] | Representative(s) | BASF IP Association BASF SE GBI-C006 67056 Ludwigshafen / DE | [2022/32] | Application number, filing date | 20789007.0 | 28.09.2020 | [2022/32] | WO2020EP77090 | Priority number, date | EP20190201400 | 04.10.2019 Original published format: EP 19201400 | EP20190204737 | 23.10.2019 Original published format: EP 19204737 | [2022/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021063880 | Date: | 08.04.2021 | Language: | EN | [2021/14] | Type: | A1 Application with search report | No.: | EP4038056 | Date: | 10.08.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.04.2021 takes the place of the publication of the European patent application. | [2022/32] | Type: | B1 Patent specification | No.: | EP4038056 | Date: | 08.11.2023 | Language: | EN | [2023/45] | Search report(s) | International search report - published on: | EP | 08.04.2021 | Classification | IPC: | C07D277/32, C07D277/40, C07D277/42 | [2023/22] | CPC: |
C07D277/40 (EP,IL,KR);
C07D277/32 (EP,CN,IL,KR,US);
C07D277/42 (EP,IL,KR)
|
Former IPC [2022/32] | C07D277/32 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/32] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | HERSTELLUNG VON 2-CHLOR-1-(2-CHLOROTHIAZOL-5-YL)ETHANON | [2022/32] | English: | PREPARATION OF 2-CHLORO-1-(2-CHLOROTHIAZOL-5-YL)ETHANONE | [2022/32] | French: | PRÉPARATION DE 2-CHLORO-1-(2-CHLOROTHIAZOL-5-YL)ÉTHANONE | [2023/22] |
Former [2022/32] | PRÉPARATION DE 2-CHLORO-1-(2-CHLOROTHIAZOL-5-YL) ÉTHANONE | Entry into regional phase | 04.05.2022 | National basic fee paid | 04.05.2022 | Designation fee(s) paid | 04.05.2022 | Examination fee paid | Examination procedure | 04.05.2022 | Examination requested [2022/32] | 04.05.2022 | Date on which the examining division has become responsible | 17.10.2022 | Amendment by applicant (claims and/or description) | 01.06.2023 | Communication of intention to grant the patent | 05.09.2023 | Fee for grant paid | 05.09.2023 | Fee for publishing/printing paid | 05.09.2023 | Receipt of the translation of the claim(s) | Opposition(s) | 09.08.2024 | No opposition filed within time limit [2024/42] | Fees paid | Renewal fee | 30.09.2022 | Renewal fee patent year 03 | 02.10.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CZ | 08.11.2023 | DK | 08.11.2023 | EE | 08.11.2023 | ES | 08.11.2023 | HR | 08.11.2023 | IT | 08.11.2023 | LT | 08.11.2023 | LV | 08.11.2023 | NL | 08.11.2023 | PL | 08.11.2023 | RO | 08.11.2023 | RS | 08.11.2023 | SE | 08.11.2023 | SI | 08.11.2023 | SK | 08.11.2023 | SM | 08.11.2023 | BG | 08.02.2024 | NO | 08.02.2024 | GR | 09.02.2024 | IS | 08.03.2024 | PT | 08.03.2024 | [2024/49] |
Former [2024/36] | CZ | 08.11.2023 | |
DK | 08.11.2023 | ||
EE | 08.11.2023 | ||
ES | 08.11.2023 | ||
HR | 08.11.2023 | ||
IT | 08.11.2023 | ||
LT | 08.11.2023 | ||
LV | 08.11.2023 | ||
NL | 08.11.2023 | ||
PL | 08.11.2023 | ||
RO | 08.11.2023 | ||
RS | 08.11.2023 | ||
SE | 08.11.2023 | ||
SK | 08.11.2023 | ||
SM | 08.11.2023 | ||
BG | 08.02.2024 | ||
NO | 08.02.2024 | ||
GR | 09.02.2024 | ||
IS | 08.03.2024 | ||
PT | 08.03.2024 | ||
Former [2024/35] | CZ | 08.11.2023 | |
DK | 08.11.2023 | ||
EE | 08.11.2023 | ||
ES | 08.11.2023 | ||
HR | 08.11.2023 | ||
LT | 08.11.2023 | ||
LV | 08.11.2023 | ||
NL | 08.11.2023 | ||
PL | 08.11.2023 | ||
RO | 08.11.2023 | ||
RS | 08.11.2023 | ||
SE | 08.11.2023 | ||
SM | 08.11.2023 | ||
BG | 08.02.2024 | ||
NO | 08.02.2024 | ||
GR | 09.02.2024 | ||
IS | 08.03.2024 | ||
PT | 08.03.2024 | ||
Former [2024/34] | DK | 08.11.2023 | |
EE | 08.11.2023 | ||
ES | 08.11.2023 | ||
HR | 08.11.2023 | ||
LT | 08.11.2023 | ||
LV | 08.11.2023 | ||
NL | 08.11.2023 | ||
PL | 08.11.2023 | ||
RS | 08.11.2023 | ||
SE | 08.11.2023 | ||
SM | 08.11.2023 | ||
BG | 08.02.2024 | ||
NO | 08.02.2024 | ||
GR | 09.02.2024 | ||
IS | 08.03.2024 | ||
PT | 08.03.2024 | ||
Former [2024/33] | DK | 08.11.2023 | |
ES | 08.11.2023 | ||
HR | 08.11.2023 | ||
LT | 08.11.2023 | ||
LV | 08.11.2023 | ||
NL | 08.11.2023 | ||
PL | 08.11.2023 | ||
RS | 08.11.2023 | ||
SE | 08.11.2023 | ||
SM | 08.11.2023 | ||
BG | 08.02.2024 | ||
NO | 08.02.2024 | ||
GR | 09.02.2024 | ||
IS | 08.03.2024 | ||
PT | 08.03.2024 | ||
Former [2024/27] | ES | 08.11.2023 | |
HR | 08.11.2023 | ||
LT | 08.11.2023 | ||
LV | 08.11.2023 | ||
NL | 08.11.2023 | ||
PL | 08.11.2023 | ||
RS | 08.11.2023 | ||
SE | 08.11.2023 | ||
BG | 08.02.2024 | ||
NO | 08.02.2024 | ||
GR | 09.02.2024 | ||
IS | 08.03.2024 | ||
PT | 08.03.2024 | ||
Former [2024/21] | LT | 08.11.2023 | |
NL | 08.11.2023 | ||
BG | 08.02.2024 | ||
GR | 09.02.2024 | ||
IS | 08.03.2024 | ||
Former [2024/20] | GR | 09.02.2024 | |
IS | 08.03.2024 | Cited in | International search | [A]WO2017021549 (ENTEROME [FR], et al) [A] 1-13* Intermediates 2e1, 2e2, 2e3, 2e4, pages 70-71 *; | [A]WO2018177970 (BASF SE [DE]) [A] 1-13 * Page 73, step 2 Page 70, step 2 *; | [AD] - T. CHALOPIN ET AL, "Second generation of thiazolylmannosides, FimH antagonists for E. coli-induced Crohn's disease", ORGANIC & BIOMOLECULAR CHEMISTRY, (20160101), vol. 14, no. 16, doi:10.1039/C6OB00424E, ISSN 1477-0520, pages 3913 - 3925, XP055658858 [AD] 1-13 * Scheme 4, page 3915 * DOI: http://dx.doi.org/10.1039/C6OB00424E | by applicant | WO2014164084 | WO2018197541 | - T. CHALOPIN et al., "Second generation of thiazolylmannosides, FimH antagonists for E. coli-induced Crohn's disease", Org. Biomol. Chem., (20160000), vol. 14, doi:10.1039/C6OB00424E, pages 3913 - 3925, XP055658858 DOI: http://dx.doi.org/10.1039/C6OB00424E |